期刊文献+

幽门螺杆菌根除率非药物影响因素的Logistic回归分析 被引量:2

Logistic regression analysis on non-pharmacological factors of helicobacter pylori eradication
下载PDF
导出
摘要 (1)目的分析影响铋剂四联方案幽门螺杆菌(Helicobacter pylori,Hp)根除率的非药物因素。(2)方法收集感染Hp的消化性溃疡或慢性胃炎患者97例,所有患者均接受铋剂四联方案根除治疗14天,疗程结束1月后复查^(14)C呼气试验。将复查结果阳性与阴性患者的临床资料进行比较,分析影响Hp根除率的非药物因素。(3)结果 97例患者中根除成功75例,根除率77.3%。研究发现,体质量指数、疾病类型与Hp根除率密切相关(P<0.05),性别、年龄、烟酒史与Hp根除率无明显相关性(P>0.05)。Logistic回归分析显示消化性溃疡OR值为0.183(95%CI 0.056~0.597),体质量指数OR值为5.838(95%CI 1.838~18.540)。(4)结论消化性溃疡、体质量指数是影响幽门螺杆菌根除率的独立因素。 Objective To analyze the non-pharmacological factors affecting on the efficacy of bismuth quadruple therapy for eradication of Helicobacter pylori(Hp).MethodsA total of 97 Hp-positive patients with peptic ulcer or chronic gastritis were recruited in this study.All patients received bismuth quadruple therapy for 14 days,and reexamined 14 C urea breath test in four weeks after the treatment.The clinical data of the patients with positive and negative results were compared,and then analyze the factors that influence on the eradication of Hp.Results A total of 75 cases were successfully eradicated in 97 patients.The eradication rate was 77.3%.Body mass index(BMI)and disease type were closely related to Hp eradication rate(P<0.05).Gender,age,smoking and alcohol consumption had no significant effect on the eradication rate of Hp(P>0.05).Logistic regression analysis showed that the OR value of the peptic ulcer was 0.183(95%CI 0.056-0.597),and the BMI was 5.838(95%CI 1.838-18.540).Conclusion The peptic ulcer and BMI are the independent factors to affect the eradication rate of Hp.
作者 杨少鹏 李志婷 徐力东 YANG Shaopeng;LI Zhiting;XU Lidong(Department of Gastroenterology,North China University of Science and Technology Affiliated Hospital,Tangshan 063000,China)
出处 《华北理工大学学报(医学版)》 2018年第2期98-101,共4页 Journal of North China University of Science and Technology:Health Sciences Edition
基金 华北理工大学研究生创新项目(编号:2016S34)
关键词 幽门螺杆菌 独立因素 消化性溃疡 慢性胃炎 Helicobacter pylori Independent factors Peptic ulcer Chronic gastritis
  • 相关文献

参考文献6

二级参考文献66

  • 1崔梅花,杨友鹏,岳林,傅怡,乙国兴,牟方宏,杨桂彬,朱红霞,张秀丽.幽门螺杆菌血清抗体对埃索美拉唑四联疗法根除效果的影响研究[J].中国全科医学,2013,16(8):850-853. 被引量:16
  • 2Hanafiah Alfizah,Awang Hamat Rukman,Ahmad Norazah,Razlan Hamizah,Mohamed Ramelah.Ethnicity association of Helicobacter pylori virulence genotype and metronidazole susceptibility[J].World Journal of Gastroenterology,2013,19(8):1283-1291. 被引量:2
  • 3Saad RJ,Schoenfeld P,Kim HM.左氧氟沙星三联疗法治疗顽固性Hp感染优于铋剂四联疗法[J].中国处方药,2006,5(5):42-42. 被引量:40
  • 4[12]Viara D, Ali A, Gatta L, O'Morain C. Treatment of Helicobacter pylori. Current Opinion in Gastroenterology: The year in Helicobacter pylori 1998; 14 (Suppl 1): 71-78
  • 5[13]Gasbarrini A, Ojetti V, Pitocco D, Franceschi F, Candelli M, Torre EL, Gabrielli M, Cammarota G, Armuzzi A, Pola P, Ghirlanda G,Gasbarrini G. Insulin-dependent diabetes mellitus affects eradication rate of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1999; 11:713-716
  • 6[14]Gasbarrini A, Ojetti V, Pitocco D, Armuzzi A, Silveri NG, Pola P, Ghirlanda G, Gasbarrini G. Efficacy of different Helicobacter pylori eradication regimens in patients affected by insulin-dependent diabetes mellitus. Scand J Gastroenterol 2000; 35:260-263
  • 7[15]Zwet VAA, Megraud F. Diagnosis. Current Opinion inGastroenterology: The year in Helicobacter pylori 1998; 14 (Suppl 1):27-33
  • 8[16]Gwilt PR, Nahas RR, Tracewell WG. The effects of diabetes mellitus on pharmocokinetics and pharmacodynamics in humans.Clin Pharmacokinet 1991; 20:477-490
  • 9[17]Megraud F. Resistance of Helicobacter pylori to antibiotics. Aliment Pharmacol Ther 1997; 11 (Suppl 1): 43-53
  • 10[18]Bessman AN, Sapico FL. Infections in the diabetic patient: the role of immune dysfunction and pathogen virulance factors. J Diabetic Complications 1992; 6:258-262

共引文献220

同被引文献20

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部